Additional file 4 of Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE)

Autor: de la Rosa, Consuelo N��hpal, Krell, Jonathan, Day, Emily, Clarke, Aaron, Reddi, Meena, Webber, Lee, Fiorentino, Francesca
Rok vydání: 2022
DOI: 10.6084/m9.figshare.17913141
Popis: Additional file 4: Supplement 1: Tables. Table 1: Schedule of Assessments for Screening. Table 2: Schedule of Assessments for: Weekly Paclitaxel alone. Table 3: Schedule of Assessments for Weekly Paclitaxel plus TAK228. Table 4: Baseline Characteristic Variables. Table 5: Laboratory parameters. Table 6: Listing of ���Most Common��� Adverse Events.
Databáze: OpenAIRE